Xanthine

Raqi Shubietah's picture

Sensitive Adsorptive Stripping Voltammetric Determination of Xanthine and its Derivatives

Journal Title, Volume, Page: 
Electroanalysis Electroanalysis Volume 7, Issue 10, pages 975–979, October 1995
Year of Publication: 
1995
Authors: 
Raqi M. Shubietah
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Current Affiliation: 
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Ali Z. Abu Zuhri
Chemistry Department, An- Najah National University, Nablus, Palestine
Arnold G. Fogg
Chemistry Department, Loughborough University of Technology, Loughborough, Leicestershire LE11 3TU, UK
Preferred Abstract (Original): 

Sensitive cathodic stripping voltammetric procedures for trace determination of xanthine (I), 7-methylxanthine (II) and 1,7-dimethylxanthine (III) are reported. The methods are based on the accumulation of the copper(I) complexes of the compounds on the hanging mercury drop electrode. The adsorptive stripping response was evaluated with respect to accumulation time, potential, concentration, pH and other variables. Linear calibration graphs were obtained over the range from 2.0 × 10−8 to 2.0 × 10−9 M; the limits of detection, with accumulation times of 4 min for I and III, and of 6 min for II, were calculated to be 5.0 × l0−10 1.0 × 10−9 and 5 × 10−10 M, respectively. Possible interferences by other purine derivatives were examined. The simultaneous determination of 1.7-dimethylxanthine (paraxanthine) and theophylline is possible by the proposed method.

2384's picture

‎1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine ‎Derivatives as Highly Potent and Selective Human A(2B) ‎Adenosine Receptor Antagonists

Journal Title, Volume, Page: 
Bioorg Med Chem.;16(5):2419-30. Epub 2007 Nov 28.
Year of Publication: 
2008
Authors: 
Abdel Naser Zaid
College of Pharmacy, An-Najah National University, Nablus, Palestine
Current Affiliation: 
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Mojgan Aghazadeh Tabrizi
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Via Fossato di Mortara 17-19, 44100 Ferrara, Italy
Pier Giovanni Baraldi
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Via Fossato di Mortara 17-19, 44100 Ferrara, Italy
Delia Preti
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Via Fossato di Mortara 17-19, 44100 Ferrara, Italy
Romeo Romagnoli
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Via Fossato di Mortara 17-19, 44100 Ferrara, Italy
Giulia Saponaro
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Via Fossato di Mortara 17-19, 44100 Ferrara, Italy
Stefania Baraldi
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Via Fossato di Mortara 17-19, 44100 Ferrara, Italy
Allan R. Moorman
King Pharmaceuticals, Inc., Research and Development, 4000 CentreGreen Way, Suite 300, Cary, North Carolina 27513, Italy
Katia Varani
Dipartimento di Medicina Clinica e Sperimentale-Sezione di Farmacologia, Università di Ferrara, 44100 Ferrara, Italy
Pier Andrea Borea
Dipartimento di Medicina Clinica e Sperimentale-Sezione di Farmacologia, Università di Ferrara, 44100 Ferrara, Italy
Preferred Abstract (Original): 

A new series of 1,3-dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives has been identified as potent A(2B) adenosine receptor antagonists. The products have been evaluated for their binding affinities for the human A(2B), A(1), A(2A), and A(3) adenosine receptors. N-(4-chloro-phenyl)-2-[3-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-5-methyl-pyrazol-1-yl] (11c) showed a high affinity for the human A(2B) adenosine receptor K(i)=7nM and good selectivity (A(1), A(2A), A(3)/A(2B)>140). Synthesis and SAR of this novel class of compounds is presented herein.

Syndicate content